{"entity":{"type":"insider","cik":"0001455549","url":"/insider/0001455549","json_url":"/insider/0001455549.json","name":"Sweeney Edward J","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":4,"first":"2010-03-02","last":"2011-03-07","span_basis":"filed_date"},"name_variants":[{"name":"Sweeney Edward J","source":"filing","n_filings":4,"first_seen":"2010-03-02","last_seen":"2011-03-07"}],"transactions":[{"id":9132754,"accession":"0001209191-11-016053","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001209191-11-016053","line_url":"/filing/0001209191-11-016053","is_derivative":false,"issuer_cik":"0001100962","issuer_name":"ENDO PHARMACEUTICALS HOLDINGS INC","issuer_ticker":"ENDP","issuer_name_source":null,"issuer_url":"/issuer/0001100962","owner_cik":"0001455549","owner_name":"Sweeney Edward J","owner_display_name":"Sweeney Edward J","owner_url":"/insider/0001455549","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock, par value, $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26390.0,"shares_display":"26,390","price_per_share":36.10374194770746,"price_display":"36.10","price_state":"stated","total_value":952777.75,"total_display":"952,777.75","total_whole":"952,778","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-03","filed_date":"2011-03-07","scope":"insider","n_lines":6},{"id":8957580,"accession":"0001209191-11-015190","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-11-015190","line_url":"/filing/0001209191-11-015190#line-2","is_derivative":false,"issuer_cik":"0001100962","issuer_name":"ENDO PHARMACEUTICALS HOLDINGS INC","issuer_ticker":"ENDP","issuer_name_source":null,"issuer_url":"/issuer/0001100962","owner_cik":"0001455549","owner_name":"Sweeney Edward J","owner_display_name":"Sweeney Edward J","owner_url":"/insider/0001455549","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock, par value $.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1110.0,"shares_display":"1,110","price_per_share":35.11,"price_display":"35.11","price_state":"stated","total_value":38972.1,"total_display":"38,972.10","total_whole":"38,972","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-01","filed_date":"2011-03-03","scope":"insider"},{"id":9073209,"accession":"0001209191-11-013042","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-11-013042","line_url":"/filing/0001209191-11-013042#line-4","is_derivative":false,"issuer_cik":"0001100962","issuer_name":"ENDO PHARMACEUTICALS HOLDINGS INC","issuer_ticker":"ENDP","issuer_name_source":null,"issuer_url":"/issuer/0001100962","owner_cik":"0001455549","owner_name":"Sweeney Edward J","owner_display_name":"Sweeney Edward J","owner_url":"/insider/0001455549","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock, par value $.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":695.0,"shares_display":"695","price_per_share":32.34,"price_display":"32.34","price_state":"stated","total_value":22476.3,"total_display":"22,476.30","total_whole":"22,476","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-21","filed_date":"2011-02-25","scope":"insider"},{"id":9073207,"accession":"0001209191-11-013042","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-11-013042","line_url":"/filing/0001209191-11-013042#line-2","is_derivative":false,"issuer_cik":"0001100962","issuer_name":"ENDO PHARMACEUTICALS HOLDINGS INC","issuer_ticker":"ENDP","issuer_name_source":null,"issuer_url":"/issuer/0001100962","owner_cik":"0001455549","owner_name":"Sweeney Edward J","owner_display_name":"Sweeney Edward J","owner_url":"/insider/0001455549","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock, par value $.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1170.0,"shares_display":"1,170","price_per_share":32.34,"price_display":"32.34","price_state":"stated","total_value":37837.8,"total_display":"37,837.80","total_whole":"37,838","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-19","filed_date":"2011-02-25","scope":"insider"},{"id":7544882,"accession":"0001209191-10-013596","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-10-013596","line_url":"/filing/0001209191-10-013596","is_derivative":false,"issuer_cik":"0001100962","issuer_name":"ENDO PHARMACEUTICALS HOLDINGS INC","issuer_ticker":"ENDP","issuer_name_source":null,"issuer_url":"/issuer/0001100962","owner_cik":"0001455549","owner_name":"Sweeney Edward J","owner_display_name":"Sweeney Edward J","owner_url":"/insider/0001455549","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock, par value $.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1805.0,"shares_display":"1,805","price_per_share":22.08972299168975,"price_display":"22.09","price_state":"stated","total_value":39871.95,"total_display":"39,871.95","total_whole":"39,872","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-03-01","filed_date":"2010-03-02","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001100962","name":"ENDO PHARMACEUTICALS HOLDINGS INC","url":"/issuer/0001100962","role":"Officer (Principal Accounting Officer)","n_filings":4,"first_seen":"2010-03-02","last_seen":"2011-03-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001455549","retrieved_at":"2026-08-25T23:38:40+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}